Differential associations of oral glucose tolerance test-derived measures of insulin sensitivity and pancreatic b-cell function with coronary artery calcification and microalbuminuria in type 2 Diabetes

Diabetes Care

Volumn 37, Issue 1, 2014, Pages 124-133

  Mulvey, Claire K ^a   McNeill, Ann M ^b   Girman, Cynthia J ^b   Churchill, Timothy W ^a   Terembula, Karen ^a   Ferguson, Jane F ^a   Shah, Rachana ^c   Mehta, Nehal N ^a   Qasim, Atif N ^d   Rickels, Michael R ^a   Reilly, Muredach P ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; ORAL ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; BODY MASS; CELL FUNCTION; CLINICAL PROTOCOL; CONTROLLED STUDY; CORONARY ARTERY CALCIFICATION; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULINOGENIC INDEX; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; MATSUDA INSULIN SENSITIVITY INDEX; METABOLIC SYNDROME X; MICROALBUMINURIA; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; RACE DIFFERENCE; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; ALBUMINURIA; BLOOD; CALCINOSIS; COMPLICATION; CORONARY ARTERY DISEASE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; METABOLISM; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; TIME;

ADULT; AGED; ALBUMINURIA; BLOOD GLUCOSE; BODY MASS INDEX; CALCINOSIS; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS; TIME FACTORS;

EID: 84892402752     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-1880     Document Type: Article

References (40)

1. Abdul-Ghani MA, Tripathy D, DeFronzo RA.Contributions of b-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 2006;29:1130-1139
2. Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes.Diabetologia 2003;46:3-19
3. Fowler MJ. Microvascular and macrovascular complications of diabetes. Clin Diabetes 2008;26:77-82
4. Brownlee M. The pathobiology of diabetic complications: A unifying mechanism.Diabetes 2005;54:1615-1625
5. Hsu CC, Chang HY, Huang MC, et al.Association between insulin resistance and development of microalbuminuria in type 2 diabetes: A prospective cohort study.Diabetes Care 2011;34:982-987
6. Jager A, Kostense PJ, Nijpels G, Heine RJ,Bouter LM, Stehouwer CD. Microalbuminuria is strongly associated with NIDDM and hypertension, but not with the insulin resistance syndrome:the Hoorn Study. Diabetologia 1998;41:694-700
7. Rizvi A, Varasteh B, Chen YD, Reaven GM.Lack of a relationship between urinary albumin excretion rate and insulin resistance in patients with non-insulindependent diabetes mellitus. Metabolism 1996;45:1062-1064
8. ADVANCE Collaborative Group; Patel A, MacMahon S, Chalmers J, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.N Engl J Med 2008;358:2560-2572
9. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837-853
10. Action to Control Cardiovascular Risk in Diabetes Study Group; Gerstein HC, Miller ME, Byington RP, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-2559
11. Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: The Framingham study. Diabetes Care 1979;2:120-126
12. Reilly MP, Wolfe ML, Rhodes T, Girman C, Mehta N, Rader DJ. Measures of insulin resistance add incremental value to the clinical diagnosis of metabolic syndrome in association with coronary atherosclerosis. Circulation 2004;110:803-809
13. Bertoni AG, Wong ND, Shea S, et al. Insulin resistance, metabolic syndrome, and subclinical atherosclerosis: The Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care 2007;30:2951-2956
14. Hanley AJ, Williams K, Stern MP, Haffner SM. Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: The San Antonio Heart Study. Diabetes Care 2002;25:1177-1184
15. Mehta NN, Krishnamoorthy P, Martin SS,et al. Usefulness of insulin resistance estimation and the metabolic syndrome in predicting coronary atherosclerosis in type 2 diabetes mellitus. Am J Cardiol 2011;107:406-411
16. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: Comparison with the euglycemic insulin clamp. Diabetes Care 1999;22:1462-1470
17. Phillips DI, Clark PM, Hales CN, Osmond C.Understanding oral glucose tolerance:comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion.Diabet Med 1994;11:286-292
18. Rumberger JA, Simons DB, Fitzpatrick LA, Sheedy PF, Schwartz RS. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. Circulation 1995;92:2157-2162
19. Rumberger JA, Sheedy PF, Breen JF,Schwartz RS. Electron beam computed tomographic coronary calcium score cutpoints and severity of associated angiographic lumen stenosis. J Am Coll Cardiol 1997;29:1542-1548
20. Kondos GT, Hoff JA, Sevrukov A, et al. Electron-beam tomography coronary artery calcium and cardiac events: A 37-month follow-up of 5635 initially asymptomatic low-to intermediate-risk adults. Circulation 2003;107:2571-2576
21. Franciosi M, Pellegrini F, Sacco M, et al.; IGLOO (Impaired Glucose tolerance, and Long-term Outcomes Observational Study) Study Group. Identifying patients at risk for microalbuminuria via interaction of the components of the metabolic syndrome:A cross-sectional analytic study. Clin J Am Soc Nephrol 2007;2:984-991
22. Martin SS, Qasim AN, Mehta NN, et al. Apolipoprotein B but not LDL cholesterol is associated with coronary artery calcification in type 2 diabetic whites. Diabetes 2009;58:1887-1892
23. Vetter ML, Cardillo S, Rickels MR, Iqbal N. Narrative review: Effect of bariatric surgery on type 2 diabetes mellitus. Ann InternMed 2009;150:94-103
24. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC.Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28:412-419
25. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004;27:1487-1495
26. Wilson PW, DAgostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-1847
27. Reilly MP, Wolfe ML, Localio AR, Rader DJ. Coronary artery calcification and cardiovascular risk factors: Impact of the analytic approach. Atherosclerosis 2004; 173:69-78
28. Cederholm J, Eliasson B, Nilsson PM, Weiss L, Gudbjornsdottir S; Steering Committee of the Swedish National Diabetes Register. Microalbuminuria and risk factors in type 1 and type 2 diabetic patients. Diabetes Res Clin Pract 2005;67:258-266
29. Howard G, OLeary DH, Zaccaro D, et al.; The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Insulin sensitivity and atherosclerosis. Circulation 1996;93:1809-1817
30. Bonora E, Targher G, Alberiche M, et al. Predictors of insulin sensitivity in Type 2 diabetes mellitus. Diabet Med 2002;19:535-542
31. Mikhail N, Tuck ML. Insulin and the vasculature. Curr Hypertens Rep 2000;2:148-153
32. Bakker W, Sipkema P, Stehouwer CD, et al. Protein kinase C u activation induces insulin-mediated constriction of muscle resistance arteries. Diabetes 2008;57:706-713
33. Ismail-Beigi F, Craven T, Banerji MA, et al.; ACCORD trial group. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: An analysis of the ACCORD randomized trial. Lancet 2010;376:419-430
34. Fonseca VA. Defining and characterizing the progression of type 2 diabetes. Diabetes Care 2009;32(Suppl 2):S151-S156
35. Esteghamati A, Ashraf H, Nakhjavani M, Najafian B, Hamidi S, Abbasi M. Insulin resistance is an independent correlate of increased urine albumin excretion: A cross-sectional study in Iranian Type 2 diabetic patients. Diabet Med 2009;26: 177-181
36. Nielsen S, Schmitz O, Orskov H, Mogensen CE. Similar insulin sensitivity in NIDDM patients with normo-and microalbuminuria. Diabetes Care 1995;18:834-842
37. Tripathy D, Almgren P, Tuomi T, Groop L.Contribution of insulin-stimulated glucose uptake and basal hepatic insulin sensitivity to surrogate measures of insulin sensitivity.Diabetes Care 2004;27:2204-2210
38. Kuo CS, Hwu CM, Chiang SC, et al. Waist circumference predicts insulin resistance in offspring of diabetic patients. Diabetes Nutr Metab 2002;15:101-108
39. Pich́e ME, Lemieux S, Corneau L, Nadeau A, Bergeron JWS, Weisnagel SJ. Measuring insulin sensitivity in postmenopausal women coveringa range of glucose tolerance: Comparison of indices derived from the oral glucose tolerance test with the euglycemic-hyperinsulinemic clamp. Metabolism 2007;56:1159-1166
40. Tura A, Kautzky-Willer A, Pacini G. Insulinogenic indices from insulin and C-peptide: Comparison of beta-cell function from OGTT and IVGTT. Diabetes Res Clin Pract 2006;72:298-301